Skip to content ↓

Topic

Medicine

Download RSS feed: News Articles / In the Media / Audio

Displaying 106 - 120 of 631 news clips related to this topic.
Show:

WHDH 7

Researchers at MIT and elsewhere have developed a new type of cancer treatment – a gel that can be used to deliver cancer drugs for solid tumors, reports WHDH. “It’s really transformative to try and help patients whose tumors are very resistant to therapy,” says Prof. Giovanni Traverso.

Newsweek

Researchers at MIT and elsewhere have developed a swallowable electronic capsule that can be used to help diagnose sleep apnea and other sleep disorders, reports Ian Randall for Newsweek. “Conventional laboratory and home sleep studies require the patient to be attached to many different sensors,” says Prof. Giovanni Traverso. “As you can imagine, trying to sleep with all of this machinery can be challenging. [The] ingestible capsule just requires that the patient swallow the vitamin-sized pill. It's easy and unobtrusive and can accurately measure both respiratory rate and heart rate while the patient sleeps."

Forbes

Cognito Therapeutics, founded by Prof. Ed Boyden and Prof. Li Huei Tsai, has developed a “specialized headset that delivers 40Hz auditory and visual stimulation” to the brain, which could potentially slow down the cognitive decline and neurodegeneration in Alzheimer’s disease, reports William A. Haseltine for Forbes. Prof. Li-Huei Tsai “and her team speculated that if gamma wave activity is reduced in Alzheimer’s disease, perhaps, artificially stimulating the brain may enhance synchronized firing and restore cognition,” writes Haseltine.

National Geographic

MIT researchers have designed a wearable ultrasound device that could help make breast cancer screening more accessible, reports Carrie Arnold for National Geographic.  “Early detection is the key for survival,” says Prof. Canan Dagdeviren. “Our humble calculation shows that this technology has the potential to save 12 million lives per year globally.”

The Boston Globe

President Biden has awarded Prof. Emeritus Subra Suresh ScD '81, the former dean of the MIT School of Engineering, the National Medal of Science for his “pioneering research across engineering, physical sciences, and life sciences,” reports Alexa Gagosz for The Boston Globe. Prof. James Fujimoto '79, SM '81, PhD '84, research affiliate Eric Swanson SM '84, and David Huang '85, SM '89, PhD '93 were awarded the National Medal of Technology and Innovation, “the nation’s highest award for technical achievement.”

Scientific American

Researchers at MIT have designed “a wearable ultrasound scanner that could be used at home to detect breast tumors earlier,” reports Simon Makin for Scientific American. “The researchers incorporated the scanner into a flexible, honeycombed 3-D-printed patch that can be fixed into a bra,” explains Makin. “The wearer moves the scanner among six different positions on the breast, where it snaps into place with magnets, allowing reproducible scanning of the whole breast.”

Forbes

Cognito Therapeutics, founded by Prof. Ed Boyden and Prof. Li-Huei Tsai, is using a 40 Hzlight-flickering and auditory headset to help slow the progression of Alzheimer’s and restore cognition, reports William A. Haseltine for Forbes. “A recent pilot clinical trial found that this technology is not only safe and tolerable for home use, but also has a positive impact on reducing symptoms associated with age-related neurodegeneration,” writes Haseltine.

Forbes

Forbes reporter Howard Gleckman spotlights Prof. Amy Finkelstein’s new book, “We’ve Got You Covered: Rebooting American Health Care.” Finkelstein and her co-author propose a, “highly provocative, radical alternative to our current mess,” by combining, “a global health budget with universal, free, basic care for everybody,” Gleckma explains.

HealthDay News

A new study by Prof. Jonathan Gruber finds that helping undocumented immigrants in the U.S. connect with primary care doctors could help reduce ER visits, reports Cara Murez for HealthDay. “The data showed a 21% drop in emergency department use, as well as a 42% drop for folks with high-risk medical profiles,” writes Murez. 

STAT

STAT reporter Annalisa Merelli writes that the 2023 Lasker Award has been given to Prof. James Fujimoto, research affiliate Eric Swanson SM ’84 and David Huang PhD ’93 for their work advancing the diagnosis of eye disease. Fujimoto, Swanson and Huang developed “optical coherence tomography (OCT) — the first noninvasive technology allowing doctors to see high-resolution images of the retina.”

The New York Times

Prof. James Fujimoto, research affiliate Eric Swanson SM ’84 and David Huang PhD ’93 have won a Lasker Award for their work inventing optical coherence tomography, which can “detect conditions like macular degeneration and diabetic retinopathy earlier than previous methods, preventing blindness,” reports Noah Weiland and Cade Metz for The New York Times. “O.C.T. now is commonly used in ophthalmology offices, where the patient simply rests a chin and forehead against an instrument for a brief scan,” write Weiland and Metz. “The method, invented in 1991, offers a staggering amount of detail about the retina.”

The Boston Globe

Prof. James Fujimoto, research affiliate Eric Swanson SM ’84 and David Huang PhD ’93 have been honored with the Lasker Award for their work for their work inventing “imaging technology that revolutionized how ophthalmologists diagnose diseases of the eye," reports Jonathan Saltzman for The Boston Globe. The scientists were recognized for developing “optical coherence tomography, or OCT, the first technology that enabled doctors to see a two- and three-dimensional cross-sectional image of the retina,” Saltzman explains. “This painless scan takes less than 10 minutes, and is now the standard of care for diagnosing retina diseases.”

7 News

7 News spotlights how MIT researchers have developed a new implantable device that could provide diabetes patients with insulin without using injections. “What we’ve been able to show is that with a minimally invasive implant that is sitting just under the skin, we’ve actually been able to sort of achieve a diabetic reversal,” explains Research Scientist Siddharth Krishnan.

Gizmodo

Gizmodo reporter Ed Cara writes that MIT researchers have developed a new implantable device that can produce its own supply of insulin for up to a month. The team envisions that the device could “eventually be used for other medical conditions dependent on a regular supply of externally produced proteins, such as certain forms of anemia treated with erythropoietin,” writes Cara.

The Daily Beast

MIT researchers have developed a new implant that in the future could be used to deliver insulin to patients for up to a month, potentially enabling patients to control diabetes without injections, reports Tony Ho Tran for the Daily Beast. In the future, the researchers hope to “develop a device for humans that would be roughly the size of a stick of gum,” writes Tran. “The implant could also be used to deliver things like drugs or proteins to help treat other diseases in humans as well.”